Skip to main navigation Skip to search Skip to main content

Bortezomib induces clinical remission and reduction of ADAMTS13 inhibitory antibodies in relapsed refractory idiopathic thrombotic thrombocytopenic purpura

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)900-902
Number of pages3
JournalBritish journal of haematology
Volume164
Issue number6
DOIs
StatePublished - Mar 2014

Keywords

  • Bortezomib
  • Thrombotic haemolytic anaemias
  • Thrombotic thrombocytopenic purpura

Cite this